Incretin & Metabolic Receptor Agonists
Tirzepatide
Also known as Mounjaro · Zepbound
FDA-approved for specific indicationsFDA-approved
Last reviewed: 2026-11-19
History
Eli Lilly researchers reported discovery of LY3298176 in 2018; initial FDA approval was in 2022.
Key sources
Targeted current-label and chronology check: November 19, 2026. Initial adult approval and later pediatric/cardiovascular expansions are distinct; trial summaries are not an exhaustive systematic review.
Related compounds
- Retatrutide
Same scientific class · A 39-amino-acid chain. · Late-stage human trials
- Semaglutide
Same scientific class · A 31-amino-acid chain. · FDA-approved for specific indications